Cargando…

SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy

Tau is a microtubule-associated protein predominantly expressed in neurons, which participates in microtubule polymerization and axonal transport. Abnormal tau metabolism leads to neurodegenerative diseases named tauopathies, such as Alzheimer’s disease and frontotemporal dementia. The alternative s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñiz, Javier Andrés, Facal, Carolina Lucía, Urrutia, Leandro, Clerici-Delville, Ramiro, Damianich, Ana, Ferrario, Juan E., Falasco, Germán, Avale, María Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Bioengineering and Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581281/ https://www.ncbi.nlm.nih.gov/pubmed/36277399 http://dx.doi.org/10.3389/fbioe.2022.951384

Ejemplares similares

Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment
por: Campolongo, Marcos, et al.
Publicado: (2018)

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022)

Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
por: Bordone, Melina P., et al.
Publicado: (2021)

Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing
por: Avale, María Elena, et al.
Publicado: (2013)

RT-QuIC detection of tauopathies using full-length tau substrates
por: Tennant, Joanne M., et al.
Publicado: (2020)

Transmission of tauopathy strains is independent of their isoform composition
por: He, Zhuohao, et al.
Publicado: (2020)

Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
por: Silva, M. Catarina, et al.
Publicado: (2020)

Impaired brain glucose metabolism and presynaptic dopaminergic functioning in a mouse model of schizophrenia
por: Tomasella, Eugenia, et al.
Publicado: (2020)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model
por: Januel, Camille, et al.
Publicado: (2022)

TDP‐43 and tau concurrence in the entorhinal subfields in primary age‐related tauopathy and preclinical Alzheimer's disease
por: Llamas‐Rodríguez, Josué, et al.
Publicado: (2023)

Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
por: Song, Mengmeng, et al.
Publicado: (2021)

Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate
por: Bondulich, Marie K., et al.
Publicado: (2016)

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
por: Quraishe, S, et al.
Publicado: (2013)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Correlation between (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in patients with Parkinson’s disease: a pilot study
por: Arena, Julieta E., et al.
Publicado: (2021)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Peripheral SMN restoration is essential for long-term rescue of a severe SMA mouse model
por: Hua, Yimin, et al.
Publicado: (2011)

Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy
por: Chang, Ching-Pang, et al.
Publicado: (2021)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

TBK1 interacts with tau and enhances neurodegeneration in tauopathy
por: Abreha, Measho H., et al.
Publicado: (2021)

Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
por: Kroth, Heiko, et al.
Publicado: (2019)

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice
por: Kordala, Anna J, et al.
Publicado: (2023)

Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
por: Cuadrado, Antonio, et al.
Publicado: (2017)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
por: Williams, Jamal B., et al.
Publicado: (2023)

Astrocytes in Tauopathies
por: Reid, Matthew J., et al.
Publicado: (2020)

Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
por: Maphis, Nicole, et al.
Publicado: (2016)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e5t7cl4aksqvqkb0vgrgbgfkjl